Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Ethosomes are a promising way to deliver drugs through the skin.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

Spironolactone is effective in treating excessive hair growth in women.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

Some sports supplements can cause health issues like mood swings, hair loss, and heart problems in men.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Traditional Chinese Medicine may help treat hair loss but needs more research.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Massaging the scalp with a cosmetic containing certain natural inhibitors can significantly regrow hair in men with pattern baldness.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.